OVERVIEW
Three expert faculty in the field of acute myeloid leukemia (AML) will take a deep-dive exploratory look at novel approaches to the treatment of AML. The program will include a didactic review of the recent clinical trial data coupled with a conversational discussion around potential clinical implications of these new data.
GOAL STATEMENT
The goal of this activity is for learners to be better able to interpret the latest data on novel approaches to the treatment of AML and to understand the potential impact on the AML therapy landscape.
LEARNING OBJECTIVES
After completing this activity, participants should be better able to: [LIST][ITEM] Identify clinical trial data on novel approaches in AML [ITEM]Recognize molecular targets and mechanisms of action of novel therapies for AML[ITEM]Interpret the latest data for novel approaches to the treatment of AML[/LIST]
ACCREDITATION STATEMENT
In support of improving patient care, this activity has been planned and implemented by Medical Learning Institute, Inc. and Medscape Oncology. Medical Learning Institute, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. [JALOGO]
[bold]For Physicians[/bold] Medical Learning Institute, Inc. (MLI) designates this live activity for a maximum of 1.0 [italic][bold]AMA PRA Category 1 Credit(s)™[/bold][/italic]. Physicians should claim only the credit commensurate with the extent of their participation in the activity. [bold]For Nurses[/bold] Successful completion of this nursing continuing professional development activity will be awarded 1.0 contact hour and 1.0 contact hour in the area of pharmacology. [bold]For Pharmacists[/bold] Medical Learning Institute, Inc. designates this continuing education activity for 1.0 contact hour (0.1 CEU) of the Accreditation Council for Pharmacy Education. Universal Activity Number: JA0007322-0000-23-073-L01-P Type of Activity: Knowledge
George R. Brown Convention Center
Meal/Theater Room 2 - Level 3
1001 Avenida De Las Americas
Houston, Texas , 77010
United States
Independent Satellite Symposium on Exploring Emerging Approaches in Acute Myeloid Leukemia, preceding the Society of Hematologic Oncology 2023 Annual Meeting.
Supported by independent educational grants from [bold] AbbVie Inc.; Biomea; Rigel Pharmaceuticals, Inc.; and Syndax Pharmaceuticals, Inc. [/bold]